Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-10-12FDA Approved: TROSPIUM CHLORIDE — Original Application (Actavis Pharma, Inc.)
FDA approves Actavis's trospium chloride as a generic for the treatment of overactive bladder.
-
FDA approval · 2012-10-10FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's OXYTROL (oxybutynin) supplemental application, enabling a label modification for the product.
-
FDA approval · 2012-08-01FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DETROL LA (tolterodine tartrate) from Viatris Specialty LLC.
-
FDA approval · 2012-08-01FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate submitted by Mylan Pharmaceuticals Inc. under NDA 020771. The drug is a tre…
-
FDA approval · 2012-08-01FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer Laboratories Div Pfizer Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-06-28FDA Approved: MYRBETRIQ — Original Application (Astellas Pharma US, Inc.)
FDA approved Mirabegron (Myrbetriq) from Astellas Pharma US for the original application, marking the initial approval for this product to t…
-
FDA approval · 2012-06-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited.
-
FDA approval · 2012-06-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride filed by Teva Pharmaceuticals USA, Inc., encompassing a labeling change thro…
-
FDA approval · 2012-05-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for trospium chloride filed by Glenmark Pharmaceuticals Inc., USA, supporting a labeling change …
-
FDA approval · 2012-04-26FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for oxybutynin chloride from Upsher-Smith Laboratories, likely updating labeling or indications.
-
FDA approval · 2012-04-26FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for oxybutynin chloride from Strides Pharma Science Limited. This action approves the generic pr…
-
FDA approval · 2011-12-30FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2011-11-04FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for oxybutynin chloride from Strides Pharma Science Limited, expanding access to this generic treatm…
-
FDA approval · 2011-11-02FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Lannett Company, expanding the availability of a generic formulation.
-
FDA approval · 2011-11-01FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer Laboratories Div Pfizer Inc. This action …
-
FDA approval · 2011-10-28FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2011-09-20FDA Approved: DETROL LA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DETROL LA (tolterodine tartrate) from Viatris Specialty LLC.
-
FDA approval · 2011-09-20FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate filed by Mylan Pharmaceuticals Inc.
-
FDA approval · 2011-03-31FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Trospium chloride from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2011-02-10FDA Approved: TOVIAZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TOVIAZ (fesoterodine fumarate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2011-01-31FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for OXYTROL (oxybutynin) from Allergan, Inc.
-
FDA approval · 2010-11-17FDA Approved: TROSPIUM CHLORIDE — Original Application (Padagis US LLC)
FDA approves the original application for trospium chloride (Padagis US LLC) for the treatment of overactive bladder.
-
FDA approval · 2010-09-20FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for oxybutynin chloride from Lannett Company, granting approval of a generic version of the drug…
-
FDA approval · 2010-08-13FDA Approved: TROSPIUM CHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original application for trospium chloride, enabling a generic version of the product.
-
FDA approval · 2010-07-12FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Vesicare (solifenacin succinate) from Astellas Pharma US, Inc., potentially updating the pro…